Total Artificial Heart, Augmented by Venovenous Extracorporeal Membrane Oxygenation

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Scott D LickZain I Khalpey

Abstract

Shortly after SynCardia total artificial heart (TAH) implant, venovenous extracorporeal membrane oxygenation (ECMO) via a 31 Fr Avalon cannula was used for profound hypoxic lung dysfunction. Immediately after starting ECMO, TAH flow increased by 1.5-2.0 L/min, presumably because of augmented TAH filling by the ECMO jet.

References

Sep 4, 1999·The Annals of Thoracic Surgery·J G CopelandM E Banchy

❮ Previous
Next ❯

Citations

Nov 4, 2017·The International Journal of Artificial Organs·Vakhtang TchantchaleishviliHoward T Massey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.